Therapeutic opportunities in targeting the protective arm of the renin-angiotensin system to improve insulin sensitivity: a mechanistic review
- 3 October 2024
- journal article
- review article
- Published by Springer Nature in Hypertension Research
- Vol. 47 (12) , 3397-3408
Abstract
In recent years, the knowledge of the physiological and pathophysiological roles of the renin-angiotensin system (RAS) in glucose metabolism has advanced significantly. It is now well-established that blockade of the angiotensin AT1 receptor (AT1R) improves insulin sensitivity. Activation of the AT2 receptor (AT2R) and the MAS receptor are significant contributors to this beneficial effect. Elevated availability of angiotensin (Ang) II) for interaction with the AT2R and increased Ang-(1–7) formation during AT1R blockade mediate these effects. The ongoing development of selective AT2R agonists, such as compound 21 and the novel Ang III peptidomimetics, has significantly advanced the exploration of the role of AT2R in metabolism and its potential as a therapeutic target. These agents show promise, particularly when RAS inhibition is contraindicated. Additionally, other RAS peptides, including Ang IV, des-Asp-Ang I, Ang-(1–9), and alamandine, hold therapeutic capability for addressing metabolic disturbances linked to type 2 diabetes. The possibility of AT2R heteromerization with either AT1R or MAS receptor offers an exciting area for future research, particularly concerning therapeutic strategies to improve glycemic control. This review focuses on therapeutic opportunities to improve insulin sensitivity, taking advantage of the protective arm of the RAS.Keywords
This publication has 124 references indexed in Scilit:
- The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.Proceedings of the National Academy of Sciences, 1995
- Effects of Angiotensin Receptor Antagonist and Angiotensin Converting Enzyme Inhibitor on Insulin Sensitivity in Fructose-Fed Hypertensive Rats and Essential HypertensivesAmerican Journal of Hypertension, 1995
- Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.Journal of Clinical Investigation, 1995
- Effects of Angiotensin II on Insulin Sensitivity and Fasting Glucose Metabolism in RatsAmerican Journal of Hypertension, 1994
- Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.Journal of Clinical Investigation, 1993
- Evidence for an intrinsic angiotensin system in the canine pancreasJournal Of Hypertension, 1991
- Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domainsCell, 1986
- Generation of angiotensin I by tissues of the human female genital tractAmerican Journal of Obstetrics and Gynecology, 1983
- Biological Activity of des-Asp1-Angiotensin I in Man*The Journal of Clinical Endocrinology & Metabolism, 1980
- Renin in dog brainAmerican Journal of Physiology-Legacy Content, 1971